DE LA CRUZ MARILYN,KARPINSKI PIOTR H.,MUTZ MICHAEL,RIEGERT CHRISTIAN,VOGEL CASPAR,SCHNEEBERGER RICARDO,CISZEWSKI LECH
申请号：
TN2011000262
公开号：
TN2011000262A1
申请日:
2011.05.23
申请国别(地区):
TN
年份:
2012
代理人:
摘要：
This invention relates to a hemifumarate salt of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I), to pharmaceutical compositions comprising this salt, to processes for forming this salt and to its use in medical treatment. In addition, the present invention also relates to new polymorphic forms of the hemifumarate salt form of Compound I, as well as to pharmaceutical compositions comprising these polymorphic forms, to processes for obtaining them, and their use in medical treatment.
